Graft Versus Host Disease Treatment Market Analysis, Development, Growth and Forecast to 2022

GLOBAL INDUSTRY INSIGHT: Graft Versus Host Disease (GVHD) Treatment Market Analysis, Size, Share, Development, Growth and Demand Forecast to 2022

Graft Versus Host Disease (GVHD) Treatment Market Analysis, Size, Share, Development, Growth and Demand Forecast to 2022

The global graft versus host disease (GVHD) treatment market is expected to witness considerable growth

due

to

increasing

number

of

hematopoietic

stem

cell

transplantations

(HSCTs),

advancement in technologies, and increasing collaboration among the pharmaceutical companies.

The regulatory bodies are supporting the graft versus host disease market by providing designations and grants for speeding up the drug development process. Currently, there are more than 15 targets, which are being used for the treatment of GVHD including T lymphocytes, OX40, Bruton's tyrosine kinase, Toll-like receptors, tumor necrosis factor alpha, neutrophil elastase, and several B and T lymphocytes. Some of the companies use their own technologies for the development of drugs for graft versus host disease such as Bellicum Pharmaceuticals, Inc. and Targazyme, Inc.

Bellicum Pharmaceuticals, Inc. is using CaspaCIDe technology and Targazyme,

Inc. is using Fucosylation technology.

Explore Report at: https://www.psmarketresearch.com/market-analysis/gvhd-treatment-market The pipeline of GVHD is very rich with more than 60 drugs. Top pharmaceutical companies such as Dr. Falk Pharma GmbH and Mallinckrodt plc are expected to launch their products in coming years, as the products are in Phase III stage of development. The therapeutics involved in the treatment of GVHD comprise different molecule types including antibody drug conjugate, antibodies, cell therapy, monoclonal antibodies and recombinant proteins.

GVHD is a common condition associated with allogeneic hematopoietic stem cell transplantation. It occurs when the donor cells are rejected and attack the recipient’s cells as foreign cell. It can progress from mild to severe forms as either acute GVHD (aGVHD) or chronic GVHD (cGVHD). The most common organs affected by aGVHD and cGVHD include skin, gastrointestinal tract, liver, oral mucosa and eyes. The affected people were recognized on the basis of number of allogeneic cell transplantation.

Request for Table of Content at: https://www.psmarketresearch.com/market-analysis/gvhdtreatment-market/toc-sample A large number of drugs have been approved for the treatment of graft versus host disease. These drugs are effective in reducing GVHD; however, many side-effects associated with their administration are hampering the growth of the global market. In addition, there are certain factors

Š P&S Market Research. All rights reserved

2

Graft Versus Host Disease (GVHD) Treatment Market Analysis, Size, Share, Development, Growth and Demand Forecast to 2022

such as wider epidemiology of disease and high cost of treatment, which remain the key challenges in the global GVHD treatment market.

Geographically, North America was the largest market for GVHD treatment in 2015, owing to the high incidence of HSCTs, high healthcare expenditure and large number of research and development activities. The U.S. contributed largest revenue to the North American GVHD treatment market and it is expected to remain the largest market globally, during the forecast period.

Explore

Other

Related

Report

at:

https://www.psmarketresearch.com/industry-

report/pharmaceuticals Some of the key players operating in the global market are Dr. Falk Pharma GmbH, Mallinckrodt Pharmaceuticals, Apceth GmbH & Co. KG, Targazyme Inc., Bellicum Pharmaceuticals, Inc., Cellect Biotechnology Ltd., Sanofi, Novartis AG, Gilead Sciences, Inc., AbbVie Inc., and Takeda Pharmaceutical Company Ltd.

About P&S Market Research P&S Market Research is a global market research and consulting company. We provide market research reports, industry reports, business intelligence and research based consulting services across a range of industries.

With the help of our professional corporate relations with various companies, our market research offers the most accurate market forecasting. Our analysts and consultants interact with leading companies of the concerned domain to substantiate every single data presented in our publication. Our research assists our client in identifying new and different windows of opportunity and frame informed and customized strategies for expansion in different regions.

Contact: Abhishek Executive – Client Partner 347, 5th Ave. #1402 New York City, NY - 10016 US/ Canada Toll-Free: 1-888-778-7886

Š P&S Market Research. All rights reserved

3

Graft Versus Host Disease (GVHD) Treatment Market Analysis, Size, Share, Development, Growth and Demand Forecast to 2022

Email: enquiry@psmarketresearch.com Web: https://www.psmarketresearch.com

Š P&S Market Research. All rights reserved

4